Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel, Dmitry I. Gabrilovich
Douglas Marvel, Dmitry I. Gabrilovich
Published July 13, 2015
Citation Information: J Clin Invest. 2015;125(9):3356-3364. https://doi.org/10.1172/JCI80005.
View: Text | PDF
Review Series Article has an altmetric score of 25

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

  • Text
  • PDF
Abstract

Our understanding of the role of myeloid-derived suppressor cells (MDSCs) in cancer is becoming increasingly complex. In addition to their eponymous role in suppressing immune responses, they directly support tumor growth, differentiation, and metastasis in a number of ways that are only now beginning to be appreciated. It is because of this increasingly complex role that these cells may become an important factor in the treatment of human cancer. In this Review, we discuss the most pertinent and controversial issues of MDSC biology and their role in promoting cancer progression and highlight how these cells may be used in the clinic, both as prognostic factors and as therapeutic targets.

Authors

Douglas Marvel, Dmitry I. Gabrilovich

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2009 Total
Citations: 18 34 51 65 80 77 62 71 79 63 7 1 608
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2018 (71)

Title and authors Publication Year
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells
Themis Alissafi, Aikaterini Hatzioannou, Konstantinos Mintzas, Roza Maria Barouni, Aggelos Banos, Sundary Sormendi, Alexandros Polyzos, Maria Xilouri, Ben Wielockx, Helen Gogas, Panayotis Verginis
Journal of Clinical Investigation 2018
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar, David Wilkes, Nina Samuel, M. Andres Blanco, Anupma Nayak, Kevin Alicea-Torres, Christian Gluck, Satrajit Sinha, Dmitry I. Gabrilovich, Rumela Chakrabarti
Journal of Clinical Investigation 2018
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash, Midan Ai, Arthur Liu, Pratha Budhani, Todd Bartkowiak, Jie Sheng, Casey R Ager, Courtney Nicholas, Ashvin R Jaiswal, Yanqiu Sun, Krishna Shah, Sadhana Balasubramanyam, Nan Li, Guocan Wang, Jing Ning, M. Anna Zal, Tomasz Zal, Michael A. Curran
Journal of Clinical Investigation 2018
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Veronica Huber, Viviana Vallacchi, Viktor Fleming, Xiaoying Hu, Agata Cova, Matteo Dugo, Eriomina Shahaj, Roberta Sulsenti, Elisabetta Vergani, Paola Filipazzi, Angela De Laurentiis, Luca Lalli, Lorenza Di Guardo, Roberto Patuzzo, Barbara Vergani, Elena Casiraghi, Mara Cossa, Ambra V Gualeni, Valentina Bollati, Flavio Arienti, Filippo de Braud, Luigi Mariani, Antonello Villa, Peter Altevogt, Viktor Umansky, Monica Rodolfo, Licia Rivoltini
Journal of Clinical Investigation 2018
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
G Qin, J Lian, L Huang, Q Zhao, S Liu, Z Zhang, X Chen, D Yue, L Li, F Li, L Wang, V Umansky, B Zhang, S Yang, Y Zhang
OncoImmunology 2018
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
M Taki, K Abiko, T Baba, J Hamanishi, K Yamaguchi, R Murakami, K Yamanoi, N Horikawa, Y Hosoe, E Nakamura, A Sugiyama, M Mandai, I Konishi, N Matsumura
Nature Communications 2018
Plasticity of myeloid-derived suppressor cells in cancer
E Tcyganov, J Mastio, E Chen, DI Gabrilovich
Current Opinion in Immunology 2018
The inflammatory function of human IgA
IS Hansen, DL Baeten, J den Dunnen
Cellular and Molecular Life Sciences 2018
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
F Hossain, S Majumder, DA Ucar, PC Rodriguez, TE Golde, LM Minter, BA Osborne, L Miele
Frontiers in immunology 2018
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
KW Moyes, A Davis, V Hoglund, K Haberthur, NA Lieberman, SA Kreuser, GH Deutsch, S Franco, D Locke, MO Carleton, DG Gilbertson, R Simmons, C Winter, J Silber, LF Gonzalez-Cuyar, RG Ellenbogen, CA Crane
OncoImmunology 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
V Fleming, X Hu, R Weber, V Nagibin, C Groth, P Altevogt, J Utikal, V Umansky
Frontiers in immunology 2018
Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer
L Barrera, E Montes-Servín, JM Hernandez-Martinez, M Orozco-Morales, E Montes-Servín, D Michel-Tello, RA Morales-Flores, D Flores-Estrada, O Arrieta
Cancer Immunology, Immunotherapy 2018
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
A Albini, A Bruno, DM Noonan, L Mortara
Frontiers in immunology 2018
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors
S Gupta, A Jain, SN Syed, RG Snodgrass, B Pflüger-Müller, MS Leisegang, A Weigert, RP Brandes, I Ebersberger, B Brüne, D Namgaladze
OncoImmunology 2018
Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
T Kitamura, D Doughty-Shenton, L Cassetta, S Fragkogianni, D Brownlie, Y Kato, N Carragher, JW Pollard
Frontiers in immunology 2018
A 2A Adenosine Receptor Gene Deletion or Synthetic A 2A Antagonist Liberate Tumor-Reactive CD8 + T Cells from Tumor-Induced Immunosuppression
J Kjaergaard, S Hatfield, G Jones, A Ohta, M Sitkovsky
Journal of immunology (Baltimore, Md. : 1950) 2018
Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
YM He, X Li, M Perego, Y Nefedova, AV Kossenkov, EA Jensen, V Kagan, YF Liu, SY Fu, QJ Ye, YH Zhou, L Wei, DI Gabrilovich, J Zhou
Nature Medicine 2018
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
MZ Afzal, RR Mercado, K Shirai
Journal for ImmunoTherapy of Cancer 2018
S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
Q Li, C Dai, R Xue, P Wang, L Chen, Y Han, U Erben, Z Qin
Frontiers in immunology 2018
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
MU Mushtaq, A Papadas, A Pagenkopf, E Flietner, Z Morrow, SG Chaudhary, F Asimakopoulos
Journal for ImmunoTherapy of Cancer 2018
Expansion of Granulocytic, Myeloid-Derived Suppressor Cells in Response to Ethanol-Induced Acute Liver Damage
S Li, N Wang, HY Tan, M Hong, MF Yuen, H Li, Y Feng
Frontiers in immunology 2018
Polymorphonuclear Leukocytes in Pulmonary Hypertension and Fibrosis: Not Always What They Appear to Be
N Durmus, G Grunig
American journal of respiratory cell and molecular biology 2018
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma
CH Yen, HH Hsiao
International journal of molecular sciences 2018
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
E Zhang, J Gu, H Xu
Molecular Cancer 2018
STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
YL Su, S Banerjee, S White, M Kortylewski
International journal of molecular sciences 2018
Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy
A Orillion, NP Damayanti, L Shen, R Adelaiye-Ogala, H Affronti, M Elbanna, S Chintala, M Ciesielski, L Fontana, C Kao, BD Elzey, TL Ratliff, DE Nelson, D Smiraglia, SI Abrams, R Pili
Clinical cancer research 2018
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
F Li, Y Zhao, L Wei, S Li, J Liu
Cancer biology & therapy 2018
Neutrophil elastase in the tumor microenvironment
I Lerman, SR Hammes
Steroids 2018
MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target
T Zhang, J Zhou, GC Man, KT Leung, B Liang, B Xiao, X Ma, S Huang, H Huang, VL Hegde, Y Zhong, Y Li, GW Kong, AK Yiu, J Kwong, PC Ng, PS Nagarkatti, M Nagarkatti, CC Wang
European Journal of Immunology 2018
Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
YS Lee, E Davila, T Zhang, HP Milmoe, SN Vogel, JS Bromberg, JR Scalea
Innate immunity 2018
Metastatic niche functions and therapeutic opportunities
T Celià-Terrassa, Y Kang
Nature Cell Biology 2018
Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression
H Mori, RD Cardiff, AD Borowsky
Frontiers in Cell and Developmental Biology 2018
The level of myeloid-derived suppressor cells positively correlates with regulatory T cells in the blood of children with transient hypogammaglobulinaemia of infancy
I Siemińska, M Rutkowska-Zapała, K Bukowska-Strakova, A Gruca, A Szaflarska, K Kobylarz, M Siedlar, J Baran
CENT EUR J IMMUNOL 2018
Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy
N Kondoh, M Mizuno-Kamiya, E Takayama, H Kawati, N Umemura, Y Yamazaki, K Mitsudo, I Tohnai
The open dentistry journal 2018
The neutrophil: one cell on many missions or many cells with different agendas?
G Christoffersson, M Phillipson
Cell and Tissue Research 2018
Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression
CM Rice, LC Davies, JJ Subleski, N Maio, M Gonzalez-Cotto, C Andrews, NL Patel, EM Palmieri, JM Weiss, JM Lee, CM Annunziata, TA Rouault, SK Durum, DW McVicar
Nature Communications 2018
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production
Y Tong, L Zhou, L Yang, P Guo, Y Cao, FX Qin, J Liu
EBioMedicine 2018
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
BJ Christmas, CI Rafie, AC Hopkins, BA Scott, HS Ma, KA Cruz, S Woolman, TD Armstrong, RM Connolly, NA Azad, EM Jaffee, ET Torres
Cancer immunology research 2018
Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation
Q Zeng, J Fu, M Korrer, M Gorbounov, PJ Murray, D Pardoll, DL Masica, YJ Kim
Cancer immunology research 2018
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, KN Weilbaecher, WG Hawkins, C Ma, RC Fields, DC Linehan, GA Challen, R Faccio, RL Aft, DG DeNardo
Nature Communications 2018
Myeloid-derived suppressor cells coming of age
F Veglia, M Perego, D Gabrilovich
Nature Immunology 2018
Adaptive NK cells resist regulatory T cell suppression driven by IL-37
D Sarhan, KL Hippen, A Lemire, S Hying, X Luo, T Lenvik, J Curtsinger, Z Davis, B Zhang, S Cooley, F Cichocki, BR Blazar, JS Miller
Cancer immunology research 2018
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
JW DiGiacomo, DM Gilkes
Targeted Oncology 2018
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
J Retseck, A Nasr, Y Lin, H Lin, P Mendiratta, LH Butterfield, AA Tarhini
Journal of Translational Medicine 2018
Immunosuppressive monocytes (CD14+/HLA-DRlow/−) increase in childhood precursor B-cell acute lymphoblastic leukemia after induction chemotherapy
DS Lima, RP Lemes, DM Matos
Medical Oncology 2018
A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy: PRECLINICAL MODEL OF SURGICAL INFLAMMATION
RW Davis, E Papasavvas, A Klampatsa, M Putt, LJ Montaner, MJ Culligan, S McNulty, JS Friedberg, CB Simone, S Singhal, SM Albelda, KA Cengel, TM Busch
Lasers in Surgery and Medicine 2018
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
H Läubli, P Müller, L DAmico, M Buchi, AS Kashyap, A Zippelius
Cancer Immunology, Immunotherapy 2018
Aberrant erythropoiesis fuels tumor growth
K Nakamura, MJ Smyth
Cell Research 2018
Microarray analysis of long non-coding RNA expression profiles in monocytic myeloid-derived suppressor cells in Echinococcus granulosus-infected mice
A Yu, Y Wang, J Yin, J Zhang, S Cao, J Cao, Y Shen
Parasites & vectors 2018
Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model
Y Qi, K Xing, L Zhang, F Zhao, M Yao, A Hu, X Wu
Journal of Cancer Research and Clinical Oncology 2018
Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer
R Yang, T Cai, X Wu, Y Liu, J He, X Zhang, G Ma, J Li
Immunology 2018
Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis
S Ambatipudi, GC Sharp, SL Clarke, D Plant, JH Tobias, DM Evans, A Barton, CL Relton
Journal of Immunology Research 2018
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
M Donadon, A Lleo, LD Tommaso, C Soldani, B Franceschini, M Roncalli, G Torzilli
Frontiers in Oncology 2018
New opportunities for nanoparticles in cancer immunotherapy
W Park, YJ Heo, DK Han
Biomaterials Research 2018
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
HG Wiktorin, MS Nilsson, R Kiffin, FE Sander, B Lenox, A Rydström, K Hellstrand, A Martner
Cancer Immunology, Immunotherapy 2018
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
A Tuccitto, E Shahaj, E Vergani, S Ferro, V Huber, M Rodolfo, C Castelli, L Rivoltini, V Vallacchi
Virchows Archiv 2018
AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34+ Progenitor Cell Engraftment in Humanized Mice
L Ling, X Tang, X Huang, J Li, H Wang, Z Chen
Journal of Neuroimmune Pharmacology 2018
Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in mice
A Francian, S Namen, M Stanley, K Mann, H Martinson, M Kullberg
Nanomedicine : nanotechnology, biology, and medicine 2018
Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
L Li, B Cao, X Liang, S Lu, H Luo, Z Wang, S Wang, J Jiang, J Lang, G Zhu
Oncogene 2018
The failure of radical treatments to cure cancer: can less deliver more?
AG Dalgleish, PL Stern
2018
Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types
AR Greenplate, DD McClanahan, BK Oberholtzer, DB Doxie, CE Roe, KE Diggins, N Leelatian, ML Rasmussen, MC Kelley, V Gama, PJ Siska, JC Rathmell, PB Ferrell, DB Johnson, JM Irish
Cancer immunology research 2018
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
H Kuroda, S Mabuchi, E Yokoi, N Komura, K Kozasa, Y Matsumoto, M Kawano, R Takahashi, T Sasano, K Shimura, M Kodama, K Hashimoto, K Sawada, E Morii, T Kimura
Oncotarget 2018
Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol
X Fei, A Wang, D Wang, X Meng, J Ma, L Hong, R Qin, A Wang, J Dong, Q Huang, Z Wang
BMC Immunology 2018
Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment
A Gonzalez-Junca, KE Driscoll, I Pellicciotta, S Du, CH Lo, R Roy, R Parry, I Tenvooren, DM Marquez, MH Spitzer, MH Barcellos-Hoff
Cancer immunology research 2018
Combining immunotherapy with radiation therapy in thoracic oncology
SN Badiyan, MC Roach, MD Chuong, SR Rice, NE Onyeuku, J Remick, S Chilukuri, E Glass, P Mohindra, CB Simone
Journal of Thoracic Disease 2018
Interferon-γ and Colorectal Cancer: an up-to date
C Kosmidis, K Sapalidis, T Koletsa, M Kosmidou, C Efthimiadis, G Anthimidis, N Varsamis, N Michalopoulos, C Koulouris, S Atmatzidis, L Liavas, TM Strati, G Koimtzis, A Tsakalidis, S Mantalovas, K Zarampouka, M Florou, DE Giannakidis, E Georgakoudi, S Baka, P Zarogoulidis, YG Man, I Kesisoglou
Journal of Cancer 2018
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
Kong YH, Xu SP
Oncology reports 2018
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.
Ilié M, Beaulande M, Ben Hadj S, Chamorey E, Schiappa R, Long-Mira E, Lassalle S, Butori C, Cohen C, Leroy S, Guérin O, Mouroux J, Marquette CH, Pomerol JF, Erb G, Hofman V, Hofman P
Cancers 2018
Resveratrol ameliorates Lewis lung carcinoma‐bearing mice development, decreases granulocytic myeloid‐derived suppressor cell accumulation and impairs its suppressive ability
Zhao Y, Shao Q, Zhu H, Xu H, Long W, Yu B, Zhou L, Xu H, Wu Y, Su Z
Cancer Science 2018
Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras
Dierckx de Casterlé I, Fevery S, Rutgeerts O, Poosti F, Struyf S, Lenaerts C, Waer M, Billiau AD, Sprangers B
Cancer Immunology, Immunotherapy 2018
Interactions among myeloid regulatory cells in cancer
Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KC, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG
Cancer Immunology, Immunotherapy 2018

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Referenced in 27 patents
On 1 Facebook pages
675 readers on Mendeley
See more details